Archives for August 2nd, 2018
Apricus Biosciences merges with Seelos Therapeutics
Custom Synthesis, Apricus Biosciences will merge with Seelos Therapeutics, Inc., a privately-held biotechnology company, in an all-stock transaction, it announced on Monday, and will...
Beximco’s fifth ANDA approved in USA
Custom Synthesis, Beximco Pharmaceuticals got approval from the US Food and Drug Administration (FDA), for its Nadolol tablets, a generic equivalent of Bristol-Myers Squibb’s Corgard,...
Single bacterial strains from the human gut microbiota can serve as HDAC inhibitors
Custom Synthesis, 4D pharma showed that specific single bacterial strains from the human gut microbiota can serve as therapeutic inhibitors of the human enzyme histone...